Faculty Opinions recommendation of Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
Keyword(s):
2006 ◽
Vol 103
(15)
◽
pp. 5941-5946
◽
Keyword(s):
2019 ◽
Vol 28
(14)
◽
pp. 933-943
◽
2019 ◽
Vol Volume 14
◽
pp. 9007-9018
◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 276
(1-2)
◽
pp. 180-186
◽
Keyword(s):
2009 ◽
Vol 215
(1-2)
◽
pp. 125-128
◽
Keyword(s):